JPWO2020247872A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020247872A5
JPWO2020247872A5 JP2021572049A JP2021572049A JPWO2020247872A5 JP WO2020247872 A5 JPWO2020247872 A5 JP WO2020247872A5 JP 2021572049 A JP2021572049 A JP 2021572049A JP 2021572049 A JP2021572049 A JP 2021572049A JP WO2020247872 A5 JPWO2020247872 A5 JP WO2020247872A5
Authority
JP
Japan
Prior art keywords
antibody
adc
antigen
seq
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021572049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536094A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/036494 external-priority patent/WO2020247872A1/en
Publication of JP2022536094A publication Critical patent/JP2022536094A/ja
Publication of JPWO2020247872A5 publication Critical patent/JPWO2020247872A5/ja
Pending legal-status Critical Current

Links

Images

JP2021572049A 2019-06-05 2020-06-05 Ｔ細胞を除去する治療法 Pending JP2022536094A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962857744P 2019-06-05 2019-06-05
US62/857,744 2019-06-05
PCT/US2020/036494 WO2020247872A1 (en) 2019-06-05 2020-06-05 T-cell depleting therapies

Publications (2)

Publication Number Publication Date
JP2022536094A JP2022536094A (ja) 2022-08-12
JPWO2020247872A5 true JPWO2020247872A5 (es) 2023-06-02

Family

ID=73652313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021572049A Pending JP2022536094A (ja) 2019-06-05 2020-06-05 Ｔ細胞を除去する治療法

Country Status (7)

Country Link
US (1) US20220249683A1 (es)
EP (1) EP3980034A4 (es)
JP (1) JP2022536094A (es)
CN (1) CN114206358A (es)
AU (1) AU2020286508A1 (es)
CA (1) CA3140447A1 (es)
WO (1) WO2020247872A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020023559A1 (en) * 2018-07-23 2020-01-30 Magenta Therapeutics, Inc. Use of an anti-cd2 antibody drug conjugate (adc) in allogeneic cell therapy
CA3107383A1 (en) * 2018-07-23 2020-01-30 Magenta Therapeutics, Inc. Use of anti-cd5 antibody drug conjugate (adc) in allogeneic cell therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006968A1 (en) * 1988-02-03 1989-08-10 Xoma Corporation Therapeutic use of anti-t cell immunotoxin for autoimmune diseases
US20060051355A1 (en) * 1998-03-23 2006-03-09 Van Oosterhout Ypke V Methods and means for the treatment of immune-related diseases
US20080254027A1 (en) * 2002-03-01 2008-10-16 Bernett Matthew J Optimized CD5 antibodies and methods of using the same
ES2584916T3 (es) * 2009-05-14 2016-09-30 Institut National de la Santé et de la Recherche Médicale Composiciones que contienen anticuerpos para tratar enfermedades relacionadas con linfocitos B o T CD5+ HLADR+
WO2018134787A2 (en) * 2017-01-20 2018-07-26 Magenta Therapeutics, Inc. Compositions and methods for the depletion of cd137+ cells
EP3700568A4 (en) * 2017-10-24 2021-11-10 Magenta Therapeutics, Inc. COMPOSITIONS AND METHODS FOR DEPLOYING CD117 + CELLS
EP3717022A4 (en) * 2017-11-29 2021-11-10 Magenta Therapeutics, Inc. COMPOSITIONS AND METHODS OF DEPLOYMENT FROM CD5 + CELLS
CA3107383A1 (en) * 2018-07-23 2020-01-30 Magenta Therapeutics, Inc. Use of anti-cd5 antibody drug conjugate (adc) in allogeneic cell therapy

Similar Documents

Publication Publication Date Title
US11572411B2 (en) Anti-CD117 antibodies and conjugates
JP7280254B2 (ja) Ｃｄ１１７＋細胞を減少させるための組成物及び方法
US20210369854A1 (en) Compositions and methods for the depletion of cd5+ cells
US20200368363A1 (en) Compositions and methods for the depletion of cd2+ cells
US20220249683A1 (en) T-cell depleting therapies
EP4051711A2 (en) Anti-cd45 antibodies and conjugates thereof
EP3958902A1 (en) Anti-cd117 antibodies and uses thereof
US20210101990A1 (en) Compositions and methods for the depletion of cd134+ cells
JPWO2020247872A5 (es)
US20210095039A1 (en) Anti-cd252 antibodies, conjugates, and methods of use
JP2022535527A (ja) 自己免疫疾患を治療するための方法および組成物
JPWO2021087368A5 (es)
JPWO2020219748A5 (es)